Jump to content

OCEL1

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Gpkp (talk | contribs) at 06:31, 21 December 2020 (+content). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

OCEL1
Identifiers
AliasesOCEL1, FWP009, S863-9, occludin/ELL domain containing 1
External IDsMGI: 1924340; HomoloGene: 11597; GeneCards: OCEL1; OMA:OCEL1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_024578

NM_001293800
NM_029865

RefSeq (protein)

NP_078854

NP_001280729
NP_084141

Location (UCSC)Chr 19: 17.23 – 17.23 MbChr 8: 71.82 – 71.83 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

OCEL1, also called Occludin//ELL Domain Containing 1, is a protein encoding gene located at chromosome 19p13.11 in the human genome.[5] Other aliases for the gene include FLJ22709, FWP009, and S863-9. The function of OCEL1 has not yet been identified.

Gene

Though the gene’s function is currently unknown, it is part of a family of genes that are related to occludin, which is an enzyme localized at tight junctions of epithelial and endothelial cells, and are also related to eleven-nineteen lysine-rich leukemia (ELL), which is an elongation factor that can increase the rate of RNA polymerase II transcription.[6][7] There are five paralogs of OCEL1 in this gene family: ELL, ELL2, ELL3, MARVELD2, and OCLN.[8] OCEL1 and each of its five paralogs all contain the Occludin/ELL Domain (pfam07303), suggesting their functions may be related to protein interactions.[6][7]

MSA for the Occludin/ELL Domain in OCEL1 and its five human paralogs. The beginnings and ends of each paralog were trimmed.

Protein

The protein encoded by OCEL1 is called Occludin/ELL Domain Containing Protein 1.[9] The protein is 264 amino acids in length. It is made up of 6 distinct exons and contains the ELL/Occludin Domain. OCEL1 has 15 different splice variations. The molecular weight of OCEL1 is approximately 28-29 kDa.[10][11] The predicted isoelectric point for the protein is 10.[11] There are 3 isoforms for the OCEL1 protein: isoform X1, isoform X2, and isoform X3.[9] Only isoforms X1 and X2 contain the ELL/Occludin Domain. The OCEL1 protein contains a proline-rich domain spanning from amino acid 28-106; the protein has two standard deviations more of proline than average.[12][13]

Tertiary structure of the human OCEL1 protein as predicted by iTASSER.[14][15]

The secondary structure of OCEL1 is predicted to contain several alpha helices but no beta pleated sheets.[14][15] There are no predicted sulfide bridges or transmembrane domains in the protein.[16][17] The tertiary structure as predicted by iTASSER shows multiple alpha helices coiling with each other.

The OCEL1 protein is localized in the Golgi apparatus, but can also be found at low levels in the nucleus.[18]

Expression

OCEL1 is expressed at detectable levels in all human tissues with low tissue specificity.[18] Expression in the kidney is low relative to other tissues during human fetal development, but is relatively higher in adults.[19][20]

Expression of OCEL1 may be regulated by several miRNA binding sites predicted to be in the 3' UTR of the gene:[21]

RNA folding of the 3’ UTR in OCEL1 generated with RNAfold Web Server.[27]

Homology and evolution

In addition to its five paralogs in the human genome, the OCEL1 gene has 234 known orthologs in other species.[9][8] Its orthologs are found in jawed vertebrates, including birds, alligators, turtles, lizards, mammals, amphibians, coelacanths, bony fish, and cartilaginous fish. Some orthologs contain both the ELL/Occludin Domain and the MARVELD2 Domain, suggesting the OCEL1 protein and MARVELD2 protein are closely related.[18]

Interacting proteins

The OCEL1 protein has been found to interact with two proteins via protein kinase assays; SRPK1, known as SRSF protein kinase I, and SRPK2, known as SRSF protein kinase II, which are both localized to the nucleus of the cell.[28] SRSF protein kinase I and II both primarily function to phosphorylate proteins at serine residues and also phosphorylates serine residue splicing factors.[29][30]

Clinical significance

The OCEL1 gene may be related to some cancers. Low expression of OCEL1 is associated with poor prognosis in patients with human non-small cell lung cancer.[31] OCEL1, when grouped with three other genes, is thought to be an effective predictor for the paclitaxel response in humans with HER2-negative breast cancer.[32]


References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000099330Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000002396Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ OCEL1 Gene - GeneCards | OCEL1 Protein | OCEL1 Antibody. [1]
  6. ^ a b Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., Tsukita, S., and Tsukita, S. (1993). Occludin: a novel integral membrane protein localizing at tight junctions. Journal of Cell Biology 123, 1777–1788.
  7. ^ a b Shilatifard, A., Lane, W.S., Jackson, K.W., Conaway, R.C., and Conaway, J.W. (1996). An RNA polymerase II elongation factor encoded by the human ELL gene. Science 271, 1873–1876.
  8. ^ a b Gene: OCEL1 (ENSG00000099330) - Paralogues - Homo_sapiens - Ensembl genome browser 101.[2]
  9. ^ a b c OCEL1 occludin/ELL domain containing 1 [Homo sapiens (human)] - Gene - NCBI.[3]
  10. ^ OCEL1 Antibody (PA5-59851)[4].
  11. ^ a b ExPASy: get pI/Mw.[5]
  12. ^ Motif Scan. [6]
  13. ^ SAPS < Sequence Statistics < EMBL-EBI.[7]
  14. ^ a b J Yang, Y Zhang. I-TASSER server: new development for protein structure and function predictions, Nucleic Acids Research, 43: W174-W181, 2015.
  15. ^ a b C Zhang, PL Freddolino, Y Zhang. COFACTOR: improved protein function prediction by combining structure, sequence and protein–protein interaction information. Nucleic Acids Research, 45: W291-W299, 2017.
  16. ^ "DISULFIND - Cysteines Disulfide Bonding State and Connectivity Predictor". disulfind.dsi.unifi.it. Retrieved 2020-04-30.
  17. ^ Hirokawa T., Boon-Chieng S., and Mitaku S., Bioinformatics, 14 378-9 (1998) SOSUI: classification and secondary structure prediction system for membrane proteins.
  18. ^ a b c OCEL1 - Occludin/ELL domain-containing protein 1 - Homo sapiens (Human) - OCEL1 gene & protein.[8]
  19. ^ Szabo, L., Morey, R., Palpant, N.J., Wang, P.L., Afari, N., Jiang, C., Parast, M.M., Murry, C.E., Laurent, L.C., and Salzman, J. (2015). Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development. Genome Biol 16, 126.
  20. ^ Fagerberg, L., Hallström, B.M., Oksvold, P., Kampf, C., Djureinovic, D., Odeberg, J., Habuka, M., Tahmasebpoor, S., Danielsson, A., Edlund, K., et al. (2014). Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13, 397–406.
  21. ^ a b c d e miRBase: microRNA sequences, targets and gene nomenclature. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4.
  22. ^ Discovery of hundreds of mirtrons in mouse and human small RNA data. Ladewig E, Okamura K, Flynt AS, Westholm JO, Lai EC. Genome Res. 2012 Sep;22(9):1634-45.
  23. ^ MicroRNA-653 Inhibits Thymocyte Proliferation and Induces Thymocyte Apoptosis in Mice with Autoimmune Myasthenia Gravis by Downregulating TRIM9. Cao YL, Dong W, Li YZ, Han W. Neuroimmunomodulation. 2019;26(1):7-18.
  24. ^ SOX30, a target gene of miR-653-5p, represses the proliferation and invasion of prostate cancer cells through inhibition of Wnt/β-catenin signaling. Fu Q, Sun Z, Yang F, Mao T, Gao Y, Wang H. Cell Mol Biol Lett. 2019 Dec 23;24:71.
  25. ^ Berezikov, E., van Tetering, G., Verheul, M., van de Belt, J., van Laake, L., Vos, J., Verloop, R., van de Wetering, M., Guryev, V., Takada, S., et al. (2006). Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res 16, 1289–1298.
  26. ^ Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A.O., Landthaler, M., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401–1414.
  27. ^ RNA folding of the 3’ UTR in OCEL1 generated with RNAfold Web Server.
  28. ^ Varjosalo, M., Keskitalo, S., Van Drogen, A., Nurkkala, H., Vichalkovski, A., Aebersold, R., and Gstaiger, M. (2013). The Protein Interaction Landscape of the Human CMGC Kinase Group. Cell Reports 3, 1306–1320.
  29. ^ Jang, S.-W., Yang, S.-J., Ehlén, A., Dong, S., Khoury, H., Chen, J., Persson, J.L., and Ye, K. (2008). Serine/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1. Cancer Res 68, 4559–4570.
  30. ^ Wang, H.Y., Lin, W., Dyck, J.A., Yeakley, J.M., Songyang, Z., Cantley, L.C., and Fu, X.D. (1998). SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. J Cell Biol 140, 737–750.
  31. ^ Deng M, Zhang Z, Liu B, Lv Q, Hou K, Che X, Qu X, Liu Y, Zhang Y, Hu X. Low OCEL1 expression is associated with poor prognosis in human non-small cell lung cancer. Cancer Biomark. 2020;27(4):519-524. doi: 10.3233/CBM-191268. PMID: 32083572.
  32. ^ Li Z, Zhang Y, Zhang Z, Zhao Z, Lv Q. A four-gene signature predicts the efficacy of paclitaxel-based neoadjuvant therapy in human epidermal growth factor receptor 2-negative breast cancer. J Cell Biochem. 2019 Apr;120(4):6046-6056. doi: 10.1002/jcb.27891. Epub 2018 Dec 5. PMID: 30520096.

Category:Genes Category:Proteins